3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
14
Breast Neoplasms
12
Neoplasms by Site
2
Neoplasms
2
Neoplasm Metastasis
2
Breast Diseases
2
Stage II Prostate Adenocarcinoma
1
Skin Diseases
1
Salivary Gland Neoplasms
1
Prostatic Neoplasms, Castration-Resistant
1
Ovarian Neoplasms
1
Metastatic Neuroendocrine Prostate Cancer
1
Inflammatory Breast Neoplasms
1
Dementia
1
Cognitive Dysfunction
1
Carcinoma, Ductal, Breast
1
Interventions
Paclitaxel
2
Letrozole
2
Carboplatin
2
Vorinostat
1
Trastuzumab
1
Taxes
1
Radiotherapy
1
Gonadotropin-Releasing Hormone
1
Fulvestrant
1
Doxorubicin
1
Docetaxel
1
Cyclophosphamide
1
Cisplatin
1
Anastrozole
1
Alpelisib
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Carcinoma, Ductal, Breast
×
Gonadotropin-Releasing Hormone
×
Clear all
NCT02221999
2023-08-29
SHPD002
RenJi Hospital
Phase 2/3
Active not recruiting
250 enrolled